Theranos & Its CEO Settle Stock Fraud Charges with SEC
...
...
...
From - Laboratory Industry Report
As the calendar turned to 2018 and Medicare turned to PAMA, diagnostic deal making revved up. Deal volume was relatively heavy although short on…
From - Laboratory Industry Report
Good news for any of you who slept through December 2017: You didn't miss much—at least as far as blockbuster strategic deals in the clinical laboratory space are…
...